ArticleHuman vaccines & immunotherapeutics2019

CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy.

January Salas-Mckee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.